Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.
There are no as such competitors for INmune Bio.
INmune Bio has a consensus price target of $9.93.
The stock price for INmune Bio (NASDAQ: INMB) is $1.4103 last updated June 18, 2026 at 7:46 PM EDT.
There are no upcoming dividends for INmune Bio.
INmune Bio does not have any upcoming earnings scheduled.
There is no upcoming split for INmune Bio.
INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.